Alberta joins lawsuit against pharmaceutical companies over opioid crisis

Last year, 746 people died after taking synthetic opioids, compared to 701 in 2017, according to data supplied by Alberta Health Services. British Columbia’s civil suit lists Purdue Pharma Inc., which manufactures OxyContin, along with other major drug producers.

It also targets pharmacies, saying pharmacists should have known the quantity of opioids they were distributing was in excess of any legitimate market demand. Alberta Health Minister Tyler Shandro said Alberta is joining the lawsuit and taking aim at manufacturers because companies “oversupplied the drugs recklessly.”In the U.S., hundreds of similar lawsuits have been filed by governments claiming the companies played a role in creating an addiction crisis that killed 42,000 Americans in 2016.

In August, an Oklahoma judge ruled drug manufacturer Johnson & Johnson intentionally downplayed the dangers, while overselling the benefits of opioids. The company was ordered it to pay $572 million. There’s no word when exactly the class-action lawsuit will be certified in British Columbia. Alberta has yet to determine the dollar amount it will seek in its suit.

But, PharmaCare now!

Good for them

Great news. Next up...benzos! And then 'medical' marijuana - it's basically sprayed with chemical versions of pills. Psychiatry is failing, as it is exposed as being quackery akin to phrenology.

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

E-cigarette companies join forces to lobby against proposed vaping regulationsThe newly-formed VITA’s goal is to help ensure regulations prevent youth access while allowing companies to advertise their products to existing smokers This is expected. What do these poison-selling companies care about the people they poison? They want to make Big $$$ for themselves and their CEOs? Big-Male-in-Sky will save you fr being poisoned. No argument here.
Sumber: globeandmail - 🏆 5. / 92 Baca lebih lajut »